▲ A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by U.S. pharmaceutical giant Pfizer Inc., at a drugstore in Seoul on Jan. 14, 2022, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap)

PM-omicron response

Gov't to lower age of eligibility for COVID-19 treatment pills from 65 to 60: PM

SEOUL, Jan. 21 (Yonhap) -- The government will lower the age of eligibility for COVID-19 treatment pills from 65 to 60 to better contain the spread of the omicron variant, Prime Minister Kim Boo-kyum said Friday.

Kim announced the measure during a COVID-19 response meeting held a day after President Moon Jae-in said omicron has become the dominant strain in the country.

The first batch of Pfizer Inc.'s COVID-19 treatment pills arrived in the country last week to be administered first to those with compromised immune systems and those aged 65 and above.

(END)

[ⓒ K-VIBE. 무단전재-재배포 금지]